ECM
ALIM

ExodusPoint Capital Management’s Alimera Sciences ALIM Stock Holding History

ExodusPoint Capital Management’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,376
Closed -$84K – 2067
2023
Q4 		$84K Buy
+19,376
New +$65.4K ﹤0.01% 1362

Other funds holding ALIM

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ExodusPoint Capital Management's ALIM Position: Q1 2024 in Review

ExodusPoint Capital Management sold out of Alimera Sciences (ALIM) in Q1 2024, closing a stake of 19,376 shares — an estimated $84K sold.

ExodusPoint Capital Management first reported a position in ALIM in Q4 2023 and held it in 1 quarter. The position peaked at $84K in Q4 2023. 39 funds tracked by Wall St. Rank hold ALIM as of Q1 2024.

  • ExodusPoint Capital Management reported no remaining Alimera Sciences position as of Q1 2024 after selling out during the quarter.
  • ExodusPoint Capital Management sold 19,376 Alimera Sciences shares in Q1 2024, an estimated $84K.
  • ExodusPoint Capital Management first reported a position in Alimera Sciences in Q4 2023 and held it in 1 quarter.
  • ExodusPoint Capital Management's Alimera Sciences position peaked at $84K in Q4 2023.
  • 39 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2024.

Based on ExodusPoint Capital Management's 13F filing for Q1 2024, filed 14 May 2024.